98 studies found for:    Open Studies | "Adrenal Gland Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
Condition: Adrenal Disease
Interventions: Procedure: PRA;   Procedure: LA
2 Not yet recruiting Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients
Condition: Adrenal Insufficiency
Intervention: Other: ACTH stimulation test
3 Recruiting Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease
Conditions: Cushing's Disease;   Corticotrophin Adenoma
Intervention: Drug: Gefitinib
4 Not yet recruiting Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Conditions: Cushing's Syndrome;   Ectopic Corticotropin Syndrome;   Adrenal Adenoma;   Adrenal Carcinoma;   AIMAH;   PPNAD
Intervention: Drug: Osilodrostat
5 Not yet recruiting MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
Condition: Cerebral Adrenoleukodystrophy
Intervention: Biological: Mesenchymal Stem Cells
6 Recruiting Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Adrenal Insufficiency
Interventions: Other: Low dose (1 mcg) ACTH stimulation test;   Other: Overnight metyrapone test
7 Recruiting Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
Condition: Adrenal Incidentalomas
Interventions: Procedure: Laparoscopic surgical removal of the adrenal tumor;   Drug: Standardized medical treatment of hypertension by SAHR
8 Recruiting Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
Condition: Primary Aldosteronism
Interventions: Other: Adrenalectomy;   Drug: mineralocorticoid receptor antagonist
9 Recruiting Hypercortisolism and Epicardial Adipose Tissue
Condition: Hypercortisolism
Interventions: Biological: Blood samples for measuring adiponectin, leptin and omentin plasma;   Device: MRI at 3 Tesla
10 Recruiting Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
Conditions: Adrenal Incidentaloma;   Adrenocortical Carcinoma
Intervention:
11 Recruiting Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
Condition: Cushings Disease
Intervention: Drug: SOM230
12 Not yet recruiting Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: metyrapone
13 Recruiting Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)
Conditions: Primary Adrenal Insufficiency;   Secondary Adrenal Insufficiency
Interventions: Drug: Plenadren;   Drug: Conventional glucocorticoid therapy
14 Recruiting UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Conditions: Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn
Intervention: Biological: DUOC-01
15 Available Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
Condition: X-linked Adrenoleukodystrophy
Intervention: Drug: Lorenzo's Oil
16 Recruiting The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention:
17 Recruiting Observational Safety and Efficacy Study of Allo-HSCT to Treat Childhood Cerebral Adrenoleukodystrophy
Condition: X-linked Adrenoleukodystrophy Cerebral Childhood
Intervention: Genetic: Allo-HSCT
18 Recruiting Cardiac Steatosis in Cushing's Syndrome
Conditions: Endocrine System Disease;   Cardiovascular Imaging
Intervention: Other: 1H magnetic resonance spectroscopy and CMRI
19 Recruiting Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: LCI699
20 Recruiting MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years